BC
IRMD icon

Broadfin Capital’s iRadimed IRMD Stock Holding History

Broadfin Capital’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-230,358
Closed -$5.61M – 92
2015
Q3 		$5.61M Sell
230,358
-125,326
-35% -$3M 0.31% 66
2015
Q2 		$8.28M Sell
355,684
-1,680
-0.5% -$30.7K 0.44% 52
2015
Q1 		$5.44M Sell
357,364
-3,520
-1% -$52K 0.42% 59
2014
Q4 		$4.66M Sell
360,884
-50,000
-12% -$432K 0.4% 52
2014
Q3 		$2.88M Buy
+410,884
New +$3.72M 0.3% 62

Other funds holding IRMD

AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.71B AUM 65.19% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
TCM
Tygh Capital Management Portland, Oregon $782M AUM 39.44% 1-Year Est. Return
CPIM
Columbia Partners Investment Management Alexandria, Virginia $257M AUM 8.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return

Broadfin Capital's IRMD Position: Q4 2015 in Review

Broadfin Capital sold out of iRadimed (IRMD) in Q4 2015, closing a stake of 230,358 shares — an estimated $5.61M sold.

Broadfin Capital first reported a position in IRMD in Q3 2014 and held it in 5 quarters. The position peaked at $8.28M in Q2 2015. 75 funds tracked by Wall St. Rank hold IRMD as of Q4 2015.

  • Broadfin Capital reported no remaining iRadimed position as of Q4 2015 after selling out during the quarter.
  • Broadfin Capital sold 230,358 iRadimed shares in Q4 2015, an estimated $5.61M.
  • Broadfin Capital first reported a position in iRadimed in Q3 2014 and held it in 5 quarters.
  • Broadfin Capital's iRadimed position peaked at $8.28M in Q2 2015.
  • 75 funds tracked by Wall St. Rank held iRadimed as of Q4 2015.

Based on Broadfin Capital's 13F filing for Q4 2015, filed 16 Feb 2016.